Back to search
Newly Diagnosed or Recurrent Metastatic Melanoma Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Newly Diagnosed or Recurrent Metastatic Melanoma Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Newly Diagnosed or Recurrent Metastatic Melanoma Patients trials you may qualify forCurrent tests to detect cancer, including CAT scans and MRI scans, are limited. PET scans use special dyes that are injected into a vein and can better localize…
RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 monoclonal antibody 3F8, can find tumor cells and carry tumor-killing substances to them wit…
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by st…
RATIONALE: MS-275 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This phase I trial is studying the side effe…
This is a prospective, open-label, non-randomized, multicenter study in adults, aged eighteen (18) or older, with newly-diagnosed or recurrent unresectable Stag…